Stock comparison
CeriBell
CBLL$713.7MHealthcare Market cap, Sector
Pro Medicus Limited
PME.AX$18.4BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
CBLL 07 PME.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CBLL0wins
7winsPME.AX
29F
B78
56D
A90
56D
A98
46D
A100
2F
B84
36F
A91
39F
A96
Side-by-side metrics
| Metric | CBLL | PME.AX |
|---|---|---|
| Market cap | $713.7M | $18.4B Winner |
| P/E (TTM) | Winner: - | 147.6x |
| EV/EBIT | Winner: - | 106.8x |
| ROIC (TTM) | -39.83% | 42.56% Winner |
| Gross margin | 87.72% | 99.85% Winner |
| Net margin | -63.51% | 54.12% Winner |
| Revenue CAGR 5y | Winner: 50.9% | 31.61% |
| EPS CAGR 5y | - | 37.34% |
| Debt / Equity | 0.2x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CBLL leads on
- EV/EBIT-vs 106.8x+110%
- P/E (TTM)-vs 147.6x+107%
- Revenue CAGR 5y50.9%vs 31.61%+38%
PME.AX leads on
- ROIC (TTM)42.56%vs -39.83%+194%
- Net margin54.12%vs -63.51%+185%
- Market cap$18.4Bvs $713.7M+96%
- Debt / Equity0.0xvs 0.2x+94%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.